Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Autocrine Fibronectin Inhibits Breast Cancer Metastasis.

Shinde A, Libring S, Alpsoy A, Abdullah A, Schaber JA, Solorio L, Wendt MK.

Mol Cancer Res. 2018 Oct;16(10):1579-1589. doi: 10.1158/1541-7786.MCR-18-0151. Epub 2018 Jun 22.

PMID:
29934326
2.

3D Jet Writing: Functional Microtissues Based on Tessellated Scaffold Architectures.

Jordahl JH, Solorio L, Sun H, Ramcharan S, Teeple CB, Haley HR, Lee KJ, Eyster TW, Luker GD, Krebsbach PH, Lahann J.

Adv Mater. 2018 Apr;30(14):e1707196. doi: 10.1002/adma.201707196. Epub 2018 Feb 27.

PMID:
29484715
3.

Tailoring the physicochemical and shape memory properties of the biodegradable polymer poly(glycerol dodecanoate) via curing conditions.

Solorio LD, Bocks ML, Hollister SJ.

J Biomed Mater Res A. 2017 Jun;105(6):1618-1623. doi: 10.1002/jbm.a.35973. Epub 2017 Mar 27.

4.

Backbone-Degradable Polymers Prepared by Chemical Vapor Deposition.

Xie F, Deng X, Kratzer D, Cheng KC, Friedmann C, Qi S, Solorio L, Lahann J.

Angew Chem Int Ed Engl. 2017 Jan 2;56(1):203-207. doi: 10.1002/anie.201609307. Epub 2016 Nov 30.

5.

Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings.

Strobel HA, Dikina AD, Levi K, Solorio LD, Alsberg E, Rolle MW.

Tissue Eng Part A. 2017 Feb;23(3-4):143-155. doi: 10.1089/ten.TEA.2016.0260. Epub 2016 Dec 6.

6.

Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.

Solorio L, Wu H, Hernandez C, Gangolli M, Exner AA.

Ther Deliv. 2016;7(4):201-12. doi: 10.4155/tde-2015-0008.

7.

Controlled Dual Growth Factor Delivery From Microparticles Incorporated Within Human Bone Marrow-Derived Mesenchymal Stem Cell Aggregates for Enhanced Bone Tissue Engineering via Endochondral Ossification.

Dang PN, Dwivedi N, Phillips LM, Yu X, Herberg S, Bowerman C, Solorio LD, Murphy WL, Alsberg E.

Stem Cells Transl Med. 2016 Feb;5(2):206-17. doi: 10.5966/sctm.2015-0115. Epub 2015 Dec 23.

8.

Effect of the Subcutaneous Environment on Phase-Sensitive In Situ-Forming Implant Drug Release, Degradation, and Microstructure.

Solorio L, Exner AA.

J Pharm Sci. 2015 Dec;104(12):4322-4328. doi: 10.1002/jps.24673. Epub 2015 Oct 27.

9.

Spatially organized differentiation of mesenchymal stem cells within biphasic microparticle-incorporated high cell density osteochondral tissues.

Solorio LD, Phillips LM, McMillan A, Cheng CW, Dang PN, Samorezov JE, Yu X, Murphy WL, Alsberg E.

Adv Healthc Mater. 2015 Oct 28;4(15):2306-13. doi: 10.1002/adhm.201500598. Epub 2015 Sep 15.

10.

The Effect of Additives on the Behavior of Phase Sensitive In Situ Forming Implants.

Solorio L, Sundarapandiyan D, Olear A, Exner AA.

J Pharm Sci. 2015 Oct;104(10):3471-80. doi: 10.1002/jps.24558. Epub 2015 Jul 14.

11.

Mathematical modelling of glycosaminoglycan production by stem cell aggregates incorporated with growth factor-releasing polymer microspheres.

Fu AS, Solorio LD, Alsberg E, Saidel GM.

J Tissue Eng Regen Med. 2017 Feb;11(2):481-488. doi: 10.1002/term.1940. Epub 2014 Jul 22.

PMID:
25047254
12.

Driving cartilage formation in high-density human adipose-derived stem cell aggregate and sheet constructs without exogenous growth factor delivery.

Dang PN, Solorio LD, Alsberg E.

Tissue Eng Part A. 2014 Dec;20(23-24):3163-75. doi: 10.1089/ten.TEA.2012.0551.

13.

Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering.

Cheng CW, Solorio LD, Alsberg E.

Biotechnol Adv. 2014 Mar-Apr;32(2):462-84. doi: 10.1016/j.biotechadv.2013.12.012. Epub 2014 Jan 10. Review.

14.

Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation.

Perera RH, Solorio L, Wu H, Gangolli M, Silverman E, Hernandez C, Peiris PM, Broome AM, Exner AA.

Pharm Res. 2014 Jun;31(6):1407-17. doi: 10.1007/s11095-013-1100-x. Epub 2013 Aug 14. Erratum in: Pharm Res. 2014 Jul;31(7):1877.

15.

Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.

Wu H, Rognin NG, Krupka TM, Solorio L, Yoshiara H, Guenette G, Sanders C, Kamiyama N, Exner AA.

Ultrasound Med Biol. 2013 Nov;39(11):2137-46. doi: 10.1016/j.ultrasmedbio.2013.05.007. Epub 2013 Aug 9.

16.

Applications of ultrasound for image-guided drug delivery in cancer chemotherapy.

Solorio L, Exner AA.

Ther Deliv. 2013 Jul;4(7):785-9. doi: 10.4155/tde.13.49.

PMID:
23883123
17.

Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.

Solorio L, Olear AM, Hamilton JI, Patel RB, Beiswenger AC, Wallace JE, Zhou H, Exner AA.

Theranostics. 2012;2(11):1064-77. doi: 10.7150/thno.4181. Epub 2012 Nov 8.

18.

Spatiotemporal regulation of chondrogenic differentiation with controlled delivery of transforming growth factor-β1 from gelatin microspheres in mesenchymal stem cell aggregates.

Solorio LD, Dhami CD, Dang PN, Vieregge EL, Alsberg E.

Stem Cells Transl Med. 2012 Aug;1(8):632-9. doi: 10.5966/sctm.2012-0039. Epub 2012 Jul 27.

19.

High-density cell systems incorporating polymer microspheres as microenvironmental regulators in engineered cartilage tissues.

Solorio LD, Vieregge EL, Dhami CD, Alsberg E.

Tissue Eng Part B Rev. 2013 Jun;19(3):209-20. doi: 10.1089/ten.TEB.2012.0252. Epub 2012 Dec 18. Review.

20.

Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging.

Solorio L, Olear AM, Zhou H, Beiswenger AC, Exner AA.

Drug Deliv Transl Res. 2012 Feb 1;2(1):45-55. doi: 10.1007/s13346-011-0054-y.

21.

Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.

Wu H, Patel RB, Zheng Y, Solorio L, Krupka TM, Ziats NP, Haaga JR, Exner AA.

Ultrasound Med Biol. 2012 Mar;38(3):443-53. doi: 10.1016/j.ultrasmedbio.2011.12.008. Epub 2012 Jan 21.

22.

Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1.

Solorio LD, Vieregge EL, Dhami CD, Dang PN, Alsberg E.

J Control Release. 2012 Mar 10;158(2):224-32. doi: 10.1016/j.jconrel.2011.11.003. Epub 2011 Nov 10.

23.

Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.

Jeon O, Powell C, Solorio LD, Krebs MD, Alsberg E.

J Control Release. 2011 Sep 25;154(3):258-66. doi: 10.1016/j.jconrel.2011.06.027. Epub 2011 Jul 2.

24.

Gelatin microspheres crosslinked with genipin for local delivery of growth factors.

Solorio L, Zwolinski C, Lund AW, Farrell MJ, Stegemann JP.

J Tissue Eng Regen Med. 2010 Oct;4(7):514-23. doi: 10.1002/term.267.

25.

Whole animal imaging.

Sandhu GS, Solorio L, Broome AM, Salem N, Kolthammer J, Shah T, Flask C, Duerk JL.

Wiley Interdiscip Rev Syst Biol Med. 2010 Jul-Aug;2(4):398-421. doi: 10.1002/wsbm.71. Review.

26.

Effect of injection site on in situ implant formation and drug release in vivo.

Patel RB, Solorio L, Wu H, Krupka T, Exner AA.

J Control Release. 2010 Nov 1;147(3):350-8. doi: 10.1016/j.jconrel.2010.08.020. Epub 2010 Aug 20.

27.

Advances in image-guided intratumoral drug delivery techniques.

Solorio L, Patel RB, Wu H, Krupka T, Exner AA.

Ther Deliv. 2010 Aug;1(2):307-22. Review.

28.

Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.

Patel RB, Carlson AN, Solorio L, Exner AA.

J Biomed Mater Res A. 2010 Aug;94(2):476-84. doi: 10.1002/jbm.a.32724.

29.

Noninvasive characterization of in situ forming implants using diagnostic ultrasound.

Solorio L, Babin BM, Patel RB, Mach J, Azar N, Exner AA.

J Control Release. 2010 Apr 19;143(2):183-90. doi: 10.1016/j.jconrel.2010.01.001. Epub 2010 Jan 11.

30.

Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Krupka TM, Solorio L, Wilson RE, Wu H, Azar N, Exner AA.

Mol Pharm. 2010 Feb 1;7(1):49-59. doi: 10.1021/mp9001816.

31.

Chondrogenic differentiation of human mesenchymal stem cell aggregates via controlled release of TGF-beta1 from incorporated polymer microspheres.

Solorio LD, Fu AS, Hernández-Irizarry R, Alsberg E.

J Biomed Mater Res A. 2010 Mar 1;92(3):1139-44. doi: 10.1002/jbm.a.32440.

Supplemental Content

Loading ...
Support Center